FIRST ON FOX — The Food and Drug Administration is phasing out an animal testing requirement for antibody therapies and other drugs in favor of testing on materials that mimic human organs, the FDA ...

The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological products and drugs, instead moving toward alternative testing models such ...

FDA Commissioner Martin Makary on Thursday announced a move away from animal-based drug testing in favor of human-based methods and artificial intelligence to determine drug safety and effectiveness.

Carlin is a vice president at Pathway Policy Group and a veterinarian. Paragas is the CEO and founder of DVLP Medicines and a virologist. The Food and Drug Administration’s recent decision to phase ...

The United States will scale back certain drug-safety testing requirements on monkeys, federal regulators said Tuesday, as President Donald Trump's administration pushes ahead with its pledge to ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal antibodies and some other drug candidates. Animal testing will be "reduced, ...

Please provide your email address to receive an email when new articles are posted on . The FDA plans to reduce and potentially replace animal testing for developing monoclonal antibody therapies and ...

The U.S. Food and Drug Administration announced earlier this month that it will be phasing out animal testing for some new drugs, and instead be using “more effective, human-relevant methods” such as ...

Around 348 B.C., Aristotle took a two-year trip to the eastern Aegean island of Lesbos to study animals in a lagoon. Along with observing the creatures in their natural habitat and surmising, among ...

Well before a human receives the first dose of an experimental drug, it’s evaluated in an animal to test for toxicity. Monkeys are often chosen for their genetic similarities to humans, and safe ...

Technical.ly is a free news resource thanks to financial supporters like Certara, a Technical.ly client, which sponsored this article. It was reviewed before publication. Learn more about Certara.

Torie Bosch is the First Opinion editor at STAT. First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech ...